Lateral Occlusion of Uterine Artery in Total Laparoscopic Hysterectomy
NCT ID: NCT02709460
Last Updated: 2019-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2016-01-31
2019-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
By coagulation of the uterine artery laterally close to the internal iliac artery this problem may be eliminated due to the much less bleeding observed during this procedure.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
NCT03707132
Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy
NCT04434066
The Efficacy of a Temporary Sub-Placental Uterine Tourniquet in Minimizing Intraoperative Blood Loss in Management of Placenta Accreta Spectrum Disorder by a Retrograde Cesarean Hysterectomy (Bladder Last)
NCT05936645
Laparoscopic Hysterectomy With Prior Uterine Artery Ligation
NCT04522232
2-D and 3-D Laparoscopic Hysterectomy
NCT02610985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The operation is done today in most cases by dividing the uterine artery at the entrance to the cervix, where the artery divides into one ascending and descending branch.
The most common complication of hysterectomy is bleeding perioperative well as postoperatively, which may result in a hematoma above the vaginal vault.
Through the years different methods have been tried to reduce this complication, including tranexamic acid without great success. The hematoma may result in infection postoperative and subsequent poor healing, with the possibility of dehiscence of the vault.
In the worst case, the gut is displaced through the vagina postoperatively. This condition can lead to diffuse peritonitis, which can be fatal in rare cases.
Since the hemostasis related to the dividing of the artery uterine can be problematic, especially in case of fibroids it may be a technical advantage to coagulate the Uterine artery at the exit of the Internal Iliac artery. This operation also ensures identification of the ureter, which can be spared. Lesions to the ureter are detected in up to 1% of all surgical procedures at hysterectomy.
Dividing of the Uterine artery at the Internal Iliac Artery also ensures that the artery can be divided with minimal bleeding at the cervix.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lateral occlusion
Women included in this arm is randomized to lateral occlusion of the uterine artery
Lateral occlusion
Lateral occlusion close to the internal Iliac artery
cervical occlusion
Women included in this arm is randomized to occlusion of the uterine artery at cervical entry
Cervical occlusion
Cervical occlusion of the uterine artery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lateral occlusion
Lateral occlusion close to the internal Iliac artery
Cervical occlusion
Cervical occlusion of the uterine artery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Women no able to understand the study or not native in Danish
* Women with uterine malignancy
* Women with suspicion of pelvic mass
* Women with abnormal coagulation
* Women receiving glucocorticoid treatment
* Women receiving anticoagulant treatment or have not followed prescription in relation to surgery
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vibeke Lysdal
Consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vibeke Lysdal
Odense, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Vibeke Lysdal, Consultant
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-20140104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.